Association of Cancer Care Centers’ Post

Today is European Skin Cancer Prevention Day! A day to raise awareness, as leaders in dermatology, about the effects of skin cancer. Skin cancer, diagnosed in its earliest stages, can exponentially increase long-term survival rates in patients. It is our duty, as professionals in the field, to help prevent its incidence. At ISD, we offer a comprehensive platform to all professionals in the dermatology field, ensuring they stay informed about industry advancements and incorporate cutting-edge insights into their practice. #ISD #InternationalSchoolDerma #EuropeanSkinCancerPreventionDay

A new publication in the Journal of Clinical and Aesthetic Dermatology (JCAD) highlights multidisciplinary consensus guidelines that recommend combining traditional staging with DecisionDx-SCC (40-GEP) to improve treatment recommendations, including the use of ART. The panel members agreed that the addition of DecisionDx-SCC testing has significant clinical utility in: -Escalation of care for lower-stage patients with high-risk tumors -De-escalation of care for patients for whom the risks of ART may outweigh the benefits -Decision-making regarding elective radiation to the nodal basin Read “Integrating 40-GEP Testing to Improve Clinical Recommendations for Adjuvant Radiation for Cutaneous Squamous Cell Carcinoma” here for more details: https://hubs.la/Q02rnpgC0

Learn about the types of non-melanoma skin cancers, potential treatments and side effects, clinical trials and the emotional concerns of a diagnosis from a Mindful Dermatology Physicians Assistant. Please register by May 7 here: https://lnkd.in/gE7NbYpz

Cutaneous T-cell lymphoma (CTCL) presents unique challenges that require a patient-focused approach to improve care and outcomes. But how can dermatologists and healthcare professionals collaborate to enhance care for CTCL patients? Dr. Larisa J. Geskin, Professor of Dermatology at Columbia University Medical Center, reviews the recommendations from a global consensus statement. She discusses how dermatologists can foster stronger multidisciplinary collaboration and adopt patient-centric strategies to address the complexities of CTCL care. Join the conversation on reshaping the future of CTCL care: https://ow.ly/7aYj50Tku2N #Dermatology #CTCL #PatientCare #HealthcareInnovation #MedicalEducation #Oncology

🩺 COLLABORATION IS VITAL: Advanced #skincancer treatment benefits greatly from partnerships between dermatologists and oncologists. Practical Dermatology Chief Medical Editor Dr. Neal Bhatia and Dr. Todd Schlesinger, a dermatologist and Practical Dermatology Editorial Board member, share their insights on the importance of teamwork as #immunotherapy technology advances. Check out the full discussion here: https://ow.ly/OzMp50STXww #dermatology #oncology

Action 4️⃣ 👉 Governments and Scientific Societies should find solutions to fill the gap left by the lack of dermatologists in the tropics, so that PWAs have access to regular skin cancer screening and management regardless of where they live. Read and share the GLOBAL CALL TO ACTION TO END THE EPIDEMIC OF SKIN CANCER IN PERSONS WITH ALBINISM: https://bit.ly/3xPETua with the support of The International League of Dermatological Societies, GlobalSkin - International Alliance of Dermatology Patient Organizations, the European Academy of Dermatology and Venereology and 30 other national and international organizations #ActionOnSkinCancerAndAlbinism #Albinism #AlbinismAwareness #SkinCancer #SkinHealthForAll

🧬 𝐖𝐡𝐲 𝐝𝐨𝐞𝐬 #𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐩𝐥𝐚𝐲 𝐚𝐧 𝐞𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐫𝐨𝐥𝐞 𝐢𝐧 𝐝𝐞𝐫𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲? In recent decades, the development of novel and highly specific therapeutics has increased a lot in dermatology, especially for conditions such as melanoma, psoriasis, and eczema. However, diagnostic techniques have not advanced at the same pace, preventing highly specific therapeutics from reaching their full potential. This large gap between diagnostics and therapeutics is being bridged by DNA- and RNA-based molecular diagnostics. Dermagnostix started on building this bridge with #PsorX – the worldwide first molecular test for the differential diagnosis of psoriasis and eczema! You want to join our journey of #MovingDiagnosticFrontiers in dermatology? Subscribe to our #newsletter: https://lnkd.in/eRCXcTVB #BeyondTheSurface #Psoriasis #Eczema

As we mark #SunAwarenessWeek, it's crucial to emphasize the importance of staying informed about skin health. Editor-in-Chief of the British Journal of Dermatology, John Ingram, underscores the significance of ongoing research in melanoma and non-melanoma skin cancer. Explore the latest insights from the BAD Journals to ensure you're equipped with knowledge and resources for prevention: https://oxford.ly/3WyH3IH British Association of Dermatologists

Journal of Dermatology for NPs & PAs co-founder and editor Douglas DiRuggiero, DMSc, MHS, PA-C, talks to Raj Chovatiya, MD, PhD, MSCI, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, IL, about how and why to encourage non-segmental #vitiligo patients to stick with daily application of ruxolitinib cream 1.5% (Opzelura, Incyte). They also discuss how this cream repigments multiple body parts in vitiligo and share tips on the best ways to address patient safety concerns. https://lnkd.in/dqhr7RW9

About 9,500 people in the U.S. are diagnosed with skin cancer every day, according to the American Academy of Dermatology Association, and 90% of those diagnosed with nonmelanoma skin cancer developed it from exposure to ultraviolet rays. Since July is UV Safety Month, we offer reminders of how to enjoy the sun safely and additional information for anyone concerned about certain spots they’ve seen on themselves or a loved one. Explore our Well-th & Well-being page for additional resources. https://lnkd.in/eeBF_-i3 #uvsafety #skincancer #wellthandwellbing #wellnessresources #sunsafety